Anti-SHP1 (phospho Y536) antibody
2
(1 Review)
|
(12 Publications)
Rabbit Polyclonal SHP1 phospho Y536 antibody. Suitable for WB, IHC-P and reacts with Mouse, Human samples. Cited in 12 publications. Immunogen corresponding to Synthetic Peptide within Human PTPN6 phospho Y536 aa 500 to C-terminus.
View Alternative Names
HCP, PTP1C, PTPN6, Tyrosine-protein phosphatase non-receptor type 6, Hematopoietic cell protein-tyrosine phosphatase, Protein-tyrosine phosphatase 1C, Protein-tyrosine phosphatase SHP-1, SH-PTP1, PTP-1C
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SHP1 (phospho Y536) antibody (AB51171)
ab51171 at 1/50 dilution staining SHP1 in human breast carcinoma by Immunohistochemistry, Paraffin embedded tissue, in the absence or presence of the immunising peptide.
- WB
Unknown
Western blot - Anti-SHP1 (phospho Y536) antibody (AB51171)
Western blot analysis of extracts from RAW264.7 cells treated with EGF (200ng/ml, 5 minutes) Western blot analysis of extracts from RAW264.7 cells treated with EGF (200ng/ml, 5 minutes)
All lanes:
Western blot - Anti-SHP1 (phospho Y536) antibody (ab51171)
Predicted band size: 68 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
SHP1 influences cell proliferation survival and differentiation by acting as a negative regulator of signaling pathways. It is not a part of a larger protein complex but it associates transiently with different receptors and substrates. It plays an important role in the immune response by regulating cytokine signaling which is important for maintaining the balance between immune activation and tolerance.
Pathways
SHP1 significantly impacts the JAK/STAT and B cell receptor signaling pathways. In the JAK/STAT pathway SHP1 interacts with JAK kinases contributing to the downregulation of cytokine signaling. In B cell receptor signaling it associates with Syk influencing immune cell activation and function.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (12)
Recent publications for all applications. Explore the full list and refine your search
Signal transduction and targeted therapy 8:236 PubMed37332010
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 9:646077 PubMed34195186
2021
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 16:e1009136 PubMed33370418
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of clinical and experimental 11:5612-5621 PubMed31949648
2018
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of experimental medicine 215:1337-1347 PubMed29669741
2018
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 8:15869 PubMed28635960
2017
Applications
Unspecified application
Species
Unspecified reactive species
Nature neuroscience 20:917-926 PubMed28530662
2017
Applications
Unspecified application
Species
Unspecified reactive species
Nature immunology 17:1273-1281 PubMed27595232
2016
Applications
WB
Species
Human
Nature cell biology 17:665-77 PubMed25915125
2015
Applications
WB
Species
Unspecified reactive species
The Journal of biological chemistry 288:16738-46 PubMed23530036
2013
Applications
Unspecified application
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com